耐药粉和2型糖尿病:临床前景
Min Kyung Kim1, Juri Park2, Doo-Man Kim1
1Department of Internal Medicine, Kangdong Sacred Heart Hospital, Hallym University College of Medicine, Seoul, South Korea.
Journal of diabetes investigation
|January 8, 2024
概括
耐性粉 (RS),一种可发酵纤维,显示出改善糖尿病患者葡萄糖代谢和胰岛素敏感性的潜力. 需要进一步的研究来证实它在治疗2型糖尿病中的作用.
科学领域:
- 营养科学 营养科学
- 代谢健康 代谢健康
- 胃肠病学 胃肠病学
背景情况:
- 碳水化合物限制可以改善糖尿病的血糖控制.
- 耐性粉 (RS) 是一种非粘性可发酵纤维,具有潜在的抗糖尿病作用.
- 肠道微生物群的RS发酵产生短链脂肪酸,影响葡萄糖调节.
研究的目的:
- 探索抗性粉在改善葡萄糖代谢中的机制和有效性.
- 评估RS作为一种饮食方法来管理2型糖尿病的潜力.
主要方法:
- 动物研究的审查和RS行动的拟议机制.
- 分析RS对葡萄糖耐受性,胰岛素敏感性和胆酸调节的影响.
- 讨论大规模人体干预试验的必要性.
主要成果:
- RS发酵通过短链脂肪酸和胆酸调节影响葡萄糖稳态.
- RS可能会降低食后葡萄糖水平,类似于低血糖指数饮食.
- 对RS对糖尿病代谢病理学的确切影响需要进一步研究.
结论:
- 耐药粉对葡萄糖调节和胰岛素敏感性有潜在的益处.
- RS可以作为2型糖尿病饮食管理的宝贵组成部分.
- 大规模的临床试验对于验证RS在糖尿病中的治疗作用至关重要.
相关概念视频
Diabetes Mellitus: Type 2 and Gestational
2.4K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.4K
Carbohydrate Metabolism
11.1K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
11.1K
Diabetes Mellitus: Overview and Type I Subtype
2.6K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.6K
Pathophysiology of Diabetes
940
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
940
Diabetes: Symptoms, Diagnosis, and Complications
546
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
546
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
176
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
Acarbose and miglitol are...
176


